We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-3 of 3

Why combatting cyber-crime is critical for life science companies
  • Gowling WLG
  • USA
  • April 27 2017

Biotech and pharmaceutical firms hold vast amounts of valuable data and information making them prime targets for cyber-attacks - so how are they



Helen Davenport
  • Gowling WLG